Table 2.
Multivariate analysis of the prognostic significance of individual clinicopathologic factors in ITGC
Clinicopathologic factors | B | SE | Wald | df | Sig | Exp(B) | 95% CI for Exp(B)
|
|
---|---|---|---|---|---|---|---|---|
Lower | Upper | |||||||
Primary tumor location | −0.232 | 0.229 | 1.031 | 1 | 0.310 | 0.793 | 0.507 | 1.241 |
Size, cm | 0.405 | 0.123 | 10.793 | 1 | 0.001 | 1.499 | 1.177 | 1.909 |
Invasion depth, mm | 0.682 | 0.285 | 5.706 | 1 | 0.017 | 1.977 | 1.130 | 3.459 |
Regional lymph node | 0.698 | 0.287 | 5.930 | 1 | 0.015 | 2.010 | 1.146 | 3.525 |
Distant metastasis | 0.870 | 0.283 | 9.428 | 1 | 0.002 | 2.388 | 1.370 | 4.162 |
TNM stage | 0.266 | 0.337 | 0.624 | 1 | 0.430 | 1.305 | 0.674 | 2.524 |
Differentiation | 0.221 | 0.161 | 1.883 | 1 | 0.170 | 1.247 | 0.910 | 1.709 |
LDH-A | 0.168 | 0.299 | 0.318 | 1 | 0.573 | 1.183 | 0.659 | 2.125 |
ZEB2 | 0.861 | 0.175 | 24.313 | 1 | 0.000 | 2.365 | 1.680 | 3.330 |
Vimentin | −0.127 | 0.158 | 0.644 | 1 | 0.422 | 0.881 | 0.646 | 1.201 |
Abbreviations: ITGC, intestinal-type gastric cancer; LDH-A, lactate dehydrogenase A.